Şunu aradınız:: shortcut method for customizing menus (Danca - İtalyanca)

since a specific method for valuing telecommunications networks is not prescribed, the voa has a choice of four methods for calculating the "rateable value" of assets.
since a specific method for valuing telecommunications networks is not prescribed, the voa has a choice of four methods for calculating the "rateable value" of assets.

referencemetoden til måling af ozon er den, der er beskrevet i en 14625:2005 »ambient air quality — standard method for the measurement of the concentration of ozone by ultraviolet photometry«.
il metodo di riferimento per la misurazione dell’ozono è descritto nella norma en 14625:2005 «ambient air quality — standard method for the measurement of the concentration of ozone by ultraviolet photometry».

referencemetoden for måling af carbonmonoxid er dem, der er beskrevet i en 14626:2005 »ambient air quality — standard method for the measurement of the concentration of carbon monoxide by nondispersive infrared spectroscopy«.
il metodo di riferimento per la misurazione del monossido di carbonio è descritto nella norma en 14626:2005 «ambient air quality — standard method for the measurement of the concentration of carbon monoxide by nondispersive infrared spectroscopy».

adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino-conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms: